IBEC’s Biomaterials for Regenerative Therapies group, led by Elisabeth Engel, will work with Avinent to develop new personalized solutions to improve treatments for bone diseases or injury. The joint research agreement will take advantage of the possibilities offered by IBEC’s 3D bioprinter.
Read the article here.
